Cue Biopharma Inc Quick ratio

Quel est le Quick ratio de Cue Biopharma Inc?

Le Quick ratio de Cue Biopharma Inc est 2.06

Quelle est la définition de Quick ratio?



«Quick ratio» est le ratio de liquidité qui mesure la capacité d'une entreprise à utiliser ses actifs rapides pour faire face à ses obligations à court terme immédiatement.

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

Quick ratio des entreprises dans Health Care secteur sur NASDAQ par rapport à Cue Biopharma Inc

Que fait Cue Biopharma Inc?

cue biopharma is an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. we design biologics to engage and modulate the activity of disease-associated t cells in the patient’s body, offering significant therapeutic advantages while potentially minimizing or eliminating unwanted side effects. we believe our biologics allow us to target antigen-specific t cell populations in a variety of indications using a simple peptide exchange within previously-validated drug frameworks developed from the cue biologics platform. this flexibility could truncate the drug selection and development process, moving effective therapeutics from discovery to clinical validation more rapidly and cost efficiently than current industry standard timelines and costs. headquartered in kendall square, cambridge, ma, we are led by an experienced management team and sci

Entreprises avec quick ratio similaire à Cue Biopharma Inc